Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
- 1 May 1999
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 37 (1) , 97-106
- https://doi.org/10.1016/s0920-9964(98)00140-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cytokine-to-brain communication: A review & analysis of alternative mechanismsPublished by Elsevier ,2000
- Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionArchiv Fur Psychiatrie Und Nervenkrankheiten, 1997
- What do we really know about late-onset schizophrenia?Archiv Fur Psychiatrie Und Nervenkrankheiten, 1997
- Clinical and Immunological Characteristics of a Subgroup of Patients Suffering from SchizophreniaPublished by S. Karger AG ,1997
- Relapse Prediction in Schizophrenia: From Monoamines to CytokinesPublished by S. Karger AG ,1997
- Elevated circulating levels of IL-6 in schizophreniaSchizophrenia Research, 1996
- Interleukin-2 as a neuroregulatory cytokineBrain Research Reviews, 1995
- Increased prevalence of antibrain antibodies in the sera from schizophrenic patientsSchizophrenia Research, 1994
- Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disordersSchizophrenia Research, 1994
- Serum interleukin-6 in schizophrenic patientsLife Sciences, 1991